Literature DB >> 18815298

Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein.

Guiqing Peng1, Yan Yan, Chengliang Zhu, Shiqun Wang, Xiaohong Yan, Lili Lu, Wei Li, Jing Hu, Wei Wei, Yongxin Mu, Yanni Chen, Yong Feng, Rui Gong, Kailang Wu, Fengmin Zhang, Xiaolian Zhang, Ying Zhu, Jianguo Wu.   

Abstract

Borna disease virus (BDV) is one of the infectious agents that causes diseases of the central nervous system in a wide range of vertebrate species and, perhaps, in humans. The phosphoprotein (P) of BDV, an essential cofactor of virus RNA-dependent RNA polymerase, is required for virus replication. In this study, we identified the gamma-aminobutyric acid receptor-associated protein (GABARAP) with functions in neurobiology as one of the viral P protein-interacting cellular factors by using an approach of phage display-based protein-protein interaction analysis. Direct binding between GABARAP and P protein was confirmed by coimmunoprecipitation, protein pull-down, and mammalian two-hybrid analyses. GABARAP originally was identified as a linker between the gamma-aminobutyric acid receptor (GABAR) and the microtubule to regulate receptor trafficking and plays important roles in the regulation of the inhibitory neural transmitter gamma-aminobutyric acid (GABA). We showed that GABARAP colocalizes with P protein in the cells infected with BDV or transfected with the P gene, which resulted in shifting the localization of GABARAP from the cytosol to the nucleus. We further demonstrated that P protein blocks the trafficking of GABAR, a principal GABA-gated ion channel that plays important roles in neural transmission, to the surface of cells infected with BDV or transfected with the P gene. We proposed that during BDV infection, P protein binds to GABARAP, shifts the distribution of GABARAP from the cytoplasm to the nucleus, and disrupts the trafficking of GABARs to the cell membranes, which may result in the inhibition of GABA-induced currents and in the enhancement of hyperactivity and anxiety.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815298      PMCID: PMC2593307          DOI: 10.1128/JVI.00877-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Constructing inhibitory synapses.

Authors:  S J Moss; T G Smart
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870

2.  Analysis of GABAA receptor assembly in mammalian cell lines and hippocampal neurons using gamma 2 subunit green fluorescent protein chimeras.

Authors:  J T Kittler; J Wang; C N Connolly; S Vicini; T G Smart; S J Moss
Journal:  Mol Cell Neurosci       Date:  2000-10       Impact factor: 4.314

3.  Structure of GABARAP in two conformations: implications for GABA(A) receptor localization and tubulin binding.

Authors:  Joseph E Coyle; Seema Qamar; Kanagalaghatta R Rajashankar; Dimitar B Nikolov
Journal:  Neuron       Date:  2002-01-03       Impact factor: 17.173

4.  Solution structure of human GABA(A) receptor-associated protein GABARAP: implications for biolgoical funcrion and its regulation.

Authors:  Thomas Stangler; Lorenz M Mayr; Dieter Willbold
Journal:  J Biol Chem       Date:  2002-03-01       Impact factor: 5.157

5.  Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1.

Authors:  W Kamitani; Y Shoya; T Kobayashi; M Watanabe; B J Lee; G Zhang; K Tomonaga; K Ikuta
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Synaptic pathology in Borna disease virus persistent infection.

Authors:  D Gonzalez-Dunia; M Watanabe; S Syan; M Mallory; E Masliah; J C De La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 7.  Molecular and cellular biology of Borna disease virus infection.

Authors:  Keizo Tomonaga; Takeshi Kobayashi; Kazuyoshi Ikuta
Journal:  Microbes Infect       Date:  2002-04       Impact factor: 2.700

8.  Modulation of Borna disease virus phosphoprotein nuclear localization by the viral protein X encoded in the overlapping open reading frame.

Authors:  Takeshi Kobayashi; Guoqi Zhang; Byeong-Jae Lee; Satoko Baba; Makiko Yamashita; Wataru Kamitani; Hideyuki Yanai; Keizo Tomonaga; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 9.  Meta-analysis of putative human bornavirus sequences fails to provide evidence implicating Borna disease virus in mental illness.

Authors:  Ralf Dürrwald; Jolanta Kolodziejek; Sibylle Herzog; Norbert Nowotny
Journal:  Rev Med Virol       Date:  2007 May-Jun       Impact factor: 6.989

Review 10.  Borna disease virus.

Authors:  I Jordan; W I Lipkin
Journal:  Rev Med Virol       Date:  2001 Jan-Feb       Impact factor: 6.989

View more
  10 in total

1.  Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression.

Authors:  Phat X Dinh; Lalit K Beura; Debasis Panda; Anshuman Das; Asit K Pattnaik
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Borna disease virus phosphoprotein modulates epigenetic signaling in neurons to control viral replication.

Authors:  Emilie M Bonnaud; Marion Szelechowski; Alexandre Bétourné; Charlotte Foret; Anne Thouard; Daniel Gonzalez-Dunia; Cécile E Malnou
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

3.  Hippocampal expression of a virus-derived protein impairs memory in mice.

Authors:  Alexandre Bétourné; Marion Szelechowski; Anne Thouard; Erika Abrial; Arnaud Jean; Falek Zaidi; Charlotte Foret; Emilie M Bonnaud; Caroline M Charlier; Elsa Suberbielle; Cécile E Malnou; Sylvie Granon; Claire Rampon; Daniel Gonzalez-Dunia
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

Review 4.  Comprehensive analysis of endogenous bornavirus-like elements in eukaryote genomes.

Authors:  Masayuki Horie; Yuki Kobayashi; Yoshiyuki Suzuki; Keizo Tomonaga
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-08-12       Impact factor: 6.237

5.  In silico and in vitro studies on the protein-protein interactions between Brugia malayi immunomodulatory protein calreticulin and human C1q.

Authors:  Sunita Yadav; Smita Gupta; Chandrabose Selvaraj; Pawan Kumar Doharey; Anita Verma; Sanjeev Kumar Singh; Jitendra Kumar Saxena
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

6.  Borna disease virus phosphoprotein impairs the developmental program controlling neurogenesis and reduces human GABAergic neurogenesis.

Authors:  Chloé Scordel; Alexandra Huttin; Marielle Cochet-Bernoin; Marion Szelechowski; Aurélie Poulet; Jennifer Richardson; Alexandra Benchoua; Daniel Gonzalez-Dunia; Marc Eloit; Muriel Coulpier
Journal:  PLoS Pathog       Date:  2015-04-29       Impact factor: 6.823

7.  Deficiency of GABARAP but not its Paralogs Causes Enhanced EGF-induced EGFR Degradation.

Authors:  Jochen Dobner; Indra M Simons; Kerstin Rufinatscha; Sebastian Hänsch; Melanie Schwarten; Oliver H Weiergräber; Iman Abdollahzadeh; Thomas Gensch; Johannes G Bode; Silke Hoffmann; Dieter Willbold
Journal:  Cells       Date:  2020-05-22       Impact factor: 6.600

Review 8.  The interplay between pathogens and Atg8 family proteins: thousand-faced interactions.

Authors:  Dávid Tóth; Gábor V Horváth; Gábor Juhász
Journal:  FEBS Open Bio       Date:  2021-11-17       Impact factor: 2.693

9.  Mutation of the protein kinase C site in borna disease virus phosphoprotein abrogates viral interference with neuronal signaling and restores normal synaptic activity.

Authors:  Christine M A Prat; Sonja Schmid; Fanny Farrugia; Nicolas Cenac; Gwendal Le Masson; Martin Schwemmle; Daniel Gonzalez-Dunia
Journal:  PLoS Pathog       Date:  2009-05-08       Impact factor: 6.823

10.  GC-MS-Based Metabonomic Profiling Displayed Differing Effects of Borna Disease Virus Natural Strain Hu-H1 and Laboratory Strain V Infection in Rat Cortical Neurons.

Authors:  Siwen Liu; Liv Bode; Lujun Zhang; Peng He; Rongzhong Huang; Lin Sun; Shigang Chen; Hong Zhang; Yujie Guo; Jingjing Zhou; Yuying Fu; Dan Zhu; Peng Xie
Journal:  Int J Mol Sci       Date:  2015-08-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.